{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T03:35:13Z","timestamp":1784000113459,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"INSERM and AP-HP"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.jneuroim.2015.10.002","type":"journal-article","created":{"date-parts":[[2015,10,14]],"date-time":"2015-10-14T11:14:02Z","timestamp":1444821242000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis"],"prefix":"10.1016","volume":"289","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2467-8177","authenticated-orcid":false,"given":"Philippe","family":"Horellou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vixra","family":"Keo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Chr\u00e9tien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ch\u00e9","family":"Serguera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Waters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumaran","family":"Deiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2015.10.002_bb0005","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1136\/jnnp-2014-308550","article-title":"Paediatric neuromyelitis optica: clinical, MRI of the brain and prognostic features","volume":"86","author":"Absoud","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2015.10.002_bb0010","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1212\/01.wnl.0000339482.84392.bd","article-title":"Incidence of acquired demyelination of the CNS in Canadian children","volume":"72","author":"Banwell","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2015.10.002_bb0015","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1159\/000371423","article-title":"C4a: an anaphylatoxin in name only","volume":"7","author":"Barnum","year":"2015","journal-title":"J. Innate Immun."},{"key":"10.1016\/j.jneuroim.2015.10.002_bb0020","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/jnnp-2014-308346","article-title":"Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein","volume":"86","author":"Baumann","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2015.10.002_bb0025","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/ana.21916","article-title":"Antibodies to native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating central nervous system disease","volume":"66","author":"Brilot","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2015.10.002_bb0030","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.addr.2011.06.005","article-title":"Complement in health and disease","volume":"63","author":"Carroll","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jneuroim.2015.10.002_bb0035","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1055\/s-2003-41281","article-title":"Interleukin-6 and oligoclonal IgG synthesis in children with acute disseminated encephalomyelitis","volume":"34","author":"Dale","year":"2003","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.jneuroim.2015.10.002_bb0040","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1002\/(SICI)1521-4141(199807)28:07<2178::AID-IMMU2178>3.0.CO;2-D","article-title":"IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis","volume":"28","author":"Eugster","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jneuroim.2015.10.002_bb0045","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0162-3109(00)80302-1","article-title":"Complement components of the innate immune system in health and disease in the CNS","volume":"49","author":"Gasque","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.jneuroim.2015.10.002_bb0050","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.4049\/jimmunol.173.5.3437","article-title":"C5a initiates the inflammatory cascade in immune complex peritonitis","volume":"173","author":"Godau","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2015.10.002_bb0055","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000081","article-title":"Myelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in children","volume":"2","author":"Hacohen","year":"2015","journal-title":"Neurol. Neuroimmunol. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2015.10.002_bb0060","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jneuroim.2006.03.020","article-title":"CSF cytokine and chemokine profiles in acute disseminated encephalomyelitis","volume":"175","author":"Ishizu","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2015.10.002_bb0065","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1096\/fj.09-138834","article-title":"C5a alters blood\u2013brain barrier integrity in experimental lupus","volume":"24","author":"Jacob","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.jneuroim.2015.10.002_bb0070","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1001\/archneur.56.3.311","article-title":"Elevated levels of antibody to myelin oligodendrocyte glycoprotein is not specific for patients with multiple sclerosis","volume":"56","author":"Karni","year":"1999","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2015.10.002_bb0075","doi-asserted-by":"crossref","DOI":"10.1177\/1352458514566666","article-title":"Anti-MOG antibodies plead against MS diagnosis in an acquired demyelinating syndromes cohort","author":"Ketelslegers","year":"2015","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2015.10.002_bb0080","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.4049\/jimmunol.173.4.2524","article-title":"Complement C5a receptor is essential for the optimal generation of antiviral CD8+ T cell responses","volume":"173","author":"Kim","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2015.10.002_bb0085","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1177\/1352458513484547","article-title":"International pediatric multiple sclerosis study group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions","volume":"19","author":"Krupp","year":"2013","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2015.10.002_bb0090","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jneuroim.2012.09.002","article-title":"Increase of complement fragment C5a in cerebrospinal fluid during exacerbation of neuromyelitis optica","volume":"254","author":"Kuroda","year":"2013","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2015.10.002_bb0095","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1073\/pnas.0510672103","article-title":"Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis","volume":"103","author":"Lalive","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2015.10.002_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1479-5876-9-111","article-title":"Complement component C5a promotes expression of IL-22 and IL-17 from human T cells and its implication in age-related macular degeneration","volume":"9","author":"Liu","year":"2011","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.jneuroim.2015.10.002_bb0105","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/1742-2094-8-184","article-title":"Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders","volume":"8","author":"Mader","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2015.10.002_bb0110","doi-asserted-by":"crossref","first-page":"4018","DOI":"10.4049\/jimmunol.162.7.4018","article-title":"Human T cells express the C5a receptor and are chemoattracted to C5a","volume":"162","author":"Nataf","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2015.10.002_bb0115","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nm1488","article-title":"Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein","volume":"13","author":"O'Connor","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2015.10.002_bb0120","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0304-3940(01)01792-X","article-title":"No association between anti-myelin oligodendrocyte glycoprotein antibodies and serum\/cerebrospinal fluid levels of the soluble interleukin-6 receptor complex in multiple sclerosis","volume":"305","author":"Padberg","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jneuroim.2015.10.002_bb0125","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2015.10.002_bb0130","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1212\/WNL.0b013e318228c0b1","article-title":"Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis","volume":"77","author":"Probstel","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2015.10.002_bb0135","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/ene.12371","article-title":"Multiple sclerosis in children and adolescents: incidence and clinical picture \u2014 new insights from the nationwide German surveillance (2009\u20132011)","volume":"21","author":"Reinhardt","year":"2014","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2015.10.002_bb0140","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1196\/annals.1422.058","article-title":"C5a receptor-deficient mice are protected from thrombophilia and endothelial cell activation induced by some antiphospholipid antibodies","volume":"1108","author":"Romay-Penabad","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2015.10.002_bb0145","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/sji.12132","article-title":"Increased soluble C5b-9 in CSF of neuromyelitis optica","volume":"79","author":"Wang","year":"2014","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.jneuroim.2015.10.002_bb0150","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.bbadis.2010.06.009","article-title":"The role of antibodies in multiple sclerosis","volume":"1812","author":"Weber","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jneuroim.2015.10.002_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072399","article-title":"Cerebrospinal fluid interleukin-6 in central nervous system inflammatory diseases","volume":"8","author":"Wullschleger","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2015.10.002_bb0160","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0165-5728(91)90014-X","article-title":"Antibodies to myelin-oligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controls","volume":"31","author":"Xiao","year":"1991","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2015.10.002_bb0165","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0165-5728(01)00483-0","article-title":"Constitutive expression of proinflammatory complement components by subsets of neurons in the central nervous system","volume":"123","author":"Yu","year":"2002","journal-title":"J. Neuroimmunol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572815300485?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572815300485?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:25:25Z","timestamp":1759047925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572815300485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":33,"alternative-id":["S0165572815300485"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2015.10.002","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2015.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}